GGrantIndex
Sort

78,016 grants matching breast cancer

Mass Cytometer CyTOF XT for Single-Cell Biology

$499,199
Won Jin Ho · Johns Hopkins University · S10 · FY2024 · OD

Characterization of a Complex Involved In Rothmund-Thomson Syndrome

$499,197
Weidong Wang · National Institute On Aging · ZIA · FY2015 · AG

Investigate the DNA damage response pathway of Fanconi anemia and BRCA proteins

$499,197
Weidong Wang · National Institute On Aging · ZIA · FY2015 · AG

A sequential therapeutic strategy of senescence induction and senolytics for elimination of surviving residual breast tumor cells

$499,191
David A. Gewirtz · Virginia Commonwealth University · R01 · FY2022 · CA

A sequential therapeutic strategy of senescence induction and senolytics for elimination of surviving residual breast tumor cells

$499,191
David A. Gewirtz · Virginia Commonwealth University · R01 · FY2023 · CA

Acquisition of a Confocal/Multiphoton Microscopy System

$499,182
Robert C Burghardt · Texas A&M University · S10 · FY2006 · RR

West Virginia CoHORTS Center

$499,142
S. Suresh Madhavan · West Virginia University · R24 · FY2009 · HS

Promoting Cancer Prevention/Control with Message Framing

$499,117
Peter Salovey · Yale University · R01 · FY2009 · CA

Bioassay for Breast Cancer Prevention

$499,063
Joellen Welsh · State University Of New York At Albany · RC1 · FY2010 · CA

TEM5 Ligand Hunt

$499,027
Bradley D St Croix · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA

GREATER DENVER LATINO CANCER PREVENTION/CONTROL NETWORK

$499,012
University Of Colorado Denver/Hsc Denver · U01 · FY2004 · CA

Ultrasound imaging and enhanced therapeutic response

$499,000
Katherine W Ferrara · University Of California At Davis · R01 · FY2016 · CA

Ultrasound imaging and enhanced therapeutic response

$499,000
Katherine W Ferrara · University Of California At Davis · R01 · FY2017 · CA

Breast and Bone Density: Impact of Colonic Environment

$498,976
Fred Hutchinson Cancer Research Center · R01 · FY2005 · CA

Targeting cell cycle and metabolic pathways of high risk breast cancers using mouse models of hyperinsulinemia

$498,956
E Premkumar Reddy · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · CA

Multiplexed mRNA and miRNA Profiling of Single Cells Phase II

$498,931
Bruce E. Seligmann · Biospyder Technologies, Inc. · R44 · FY2017 · HG

Multiplexed mRNA and miRNA Profiling of Single Cells Phase II

$498,930
Bruce E. Seligmann · Biospyder Technologies, Inc. · R44 · FY2016 · HG

LEGACY: A cohort of youth in families from the Breast Cancer Family Registry

$498,890
Mary Beth Terry · Columbia University Health Sciences · R01 · FY2011 · CA

SPORE IN BREAST CANCER

$498,853
Johns Hopkins University · P50 · FY2005 · CA

Comparative effectiveness research using NCCN data

$498,853
Jane C. Weeks · Dana-Farber Cancer Inst · RC1 · FY2010 · CA

Analyzer-based Phase Contrast Imaging System Development and Evaluation

$498,851
Jovan G Brankov · Illinois Institute Of Technology · R01 · FY2020 · EB

A population-based approach to single CTC analysis in metastatic breast cancer outcome

$498,850
Hushan Yang · Thomas Jefferson University · R01 · FY2017 · CA

Molecular Characterization of Breast Duct Epithelium at Risk for Breast Cancer

$498,834
David Danforth · Division Of Clinical Sciences - Nci · ZIA · FY2020 · CA

Role of ACER2 in cancer chemoresistance and metastasis

$498,825
Cungui Mao · State University New York Stony Brook · R01 · FY2023 · CA

Occupational and Environmental Determinants of Cancer among Women and Minorities

$498,809
Laura Beane Freeman · Division Of Cancer Epidemiology And Genetics · ZIA · FY2015 · CA